Julian Gold
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Evaluation of triumeq treatment on a TDP-43 mouse model of amyotrophic Lateral sclerosis.
Journal: Scientific reports
Published: February 05, 2026
Motor Neuron Disease Mortality Trends in Australia From 1986 to 2023: A Population-Based Study.
Journal: The Medical journal of Australia
Published: August 08, 2025
The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.
Journal: Brain : a journal of neurology
Published: December 09, 2024
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 22, 2023
Effect of teriflunomide on Epstein-Barr virus shedding in relapsing-remitting multiple sclerosis patients: Outcomes from a real-world pilot cohort study.
Journal: Multiple sclerosis and related disorders
Published: July 14, 2022
Is EBV the cause of multiple sclerosis?
Journal: Multiple sclerosis and related disorders
Published: February 03, 2022
Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia.
Journal: Communications medicine
Published: January 27, 2022
The COVID-19 pandemic and the use of MS disease-modifying therapies.
Journal: Multiple sclerosis and related disorders
Published: April 27, 2020
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 10, 2019
Epstein Barr virus shedding in multiple sclerosis: Similar frequencies of EBV in saliva across separate patient cohorts.
Journal: Multiple sclerosis and related disorders
Published: February 19, 2018
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.
Journal: Multiple sclerosis and related disorders
Published: January 30, 2018
Human Endogenous Retroviruses in Neurological Diseases.
Journal: Trends in molecular medicine
Published: December 09, 2017
Last Updated: 09/26/2026